- Home
- CAPR vs LDP Comparison
CAPR vs LDP Comparison
Compare CAPR & LDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAPR
- LDP
- Stock Information
- Founded
- CAPR 2005
- LDP 2012
- Country
- CAPR United States
- LDP United States
- Employees
- CAPR N/A
- LDP N/A
- Industry
- CAPR Biotechnology: Biological Products (No Diagnostic Substances)
- LDP Finance Companies
- Sector
- CAPR Health Care
- LDP Finance
- Exchange
- CAPR Nasdaq
- LDP Nasdaq
- Market Cap
- CAPR 578.4M
- LDP 607.2M
- IPO Year
- CAPR N/A
- LDP N/A
- Fundamental
- Price
- CAPR $14.06
- LDP $20.59
- Analyst Decision
- CAPR Strong Buy
- LDP
- Analyst Count
- CAPR 7
- LDP 0
- Target Price
- CAPR $39.29
- LDP N/A
- AVG Volume (30 Days)
- CAPR 1.1M
- LDP 102.5K
- Earning Date
- CAPR 02-27-2025
- LDP 01-01-0001
- Dividend Yield
- CAPR N/A
- LDP 7.91%
- EPS Growth
- CAPR N/A
- LDP N/A
- EPS
- CAPR N/A
- LDP N/A
- Revenue
- CAPR $23,228,045.00
- LDP N/A
- Revenue This Year
- CAPR N/A
- LDP N/A
- Revenue Next Year
- CAPR $74.85
- LDP N/A
- P/E Ratio
- CAPR N/A
- LDP N/A
- Revenue Growth
- CAPR 65.33
- LDP N/A
- 52 Week Low
- CAPR $3.52
- LDP $16.16
- 52 Week High
- CAPR $23.40
- LDP $20.30
- Technical
- Relative Strength Index (RSI)
- CAPR 48.54
- LDP 53.11
- Support Level
- CAPR $12.31
- LDP $20.11
- Resistance Level
- CAPR $16.17
- LDP $20.66
- Average True Range (ATR)
- CAPR 0.82
- LDP 0.24
- MACD
- CAPR 0.11
- LDP 0.05
- Stochastic Oscillator
- CAPR 45.34
- LDP 90.00
About CAPR Capricor Therapeutics Inc.
Capricor Therapeutics Inc is a biotechnology company focused on advancing transformative cell and exosome-based therapeutics to redefine the treatment landscape for rare diseases. The company's product pipeline includes CAP-1002, deramiocel an allogeneic cardiac-derived cell therapy. Deramiocel is currently advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy. Through its proprietary StealthXTM platform, the group uses its exosome technology to conduct preclinical research focused on vaccinology, delivering oligonucleotides, proteins, and small molecules to treat and prevent a wide range of diseases with targeted delivery.
About LDP Cohen & Steers Limited Duration Preferred and Income Fund Inc.
Cohen & Steers Ltd Duration Preferred & Income Fund, Inc. is a diversified, closed-end management investment company. Its primary investment objective is high current income and capital appreciation is its secondary investment objective. The Fund invests at least its managed assets in preferred and other income securities issued by U.S. and non-U.S. companies under normal market conditions.